Predictors of Residual Cardiovascular Risk in Patients on Statin Therapy for Primary Prevention

Publisher： Karger

E-ISSN： 1421-9751|119|4|187-190

ISSN： 0008-6312

Source： Cardiology, Vol.119, Iss.4, 2011-09, pp. : 187-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia

By  

Cardiology, Vol. 135, Iss. 1, 2016-05 ,pp. : 3-12

Karger

Access to resources Recommend Favorite

Primary prevention trials: lessons learned about treating high-risk patients with dyslipidemia without known cardiovascular disease

By Ferdinand Keith C.  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1091-1098

Informa Healthcare

Access to resources Recommend Favorite

Estimation of cardiovascular risk in hypertensive patients in primary care

By Montgomery Alan A.   Fahey Tom   MacKintosh Christopher   Sharp Deborah J.   Peters Tim J.  

British Journal of General Practice, Vol. 50, Iss. 451, 2000-02 ,pp. : 127-128

Royal College of General Practitioners

Access to resources Recommend Favorite

Predictors of cardiovascular risk in women

By Sallam Tamer   Watson Karol E  

Women's Health, Vol. 9, Iss. 5, 2013-09 ,pp. : 491-498

Future Medicine

Access to resources Recommend Favorite

Cardiovascular risk and lipid management beyond statin therapy: the potential role of omega-3 polyunsaturated fatty acid ethyl esters

By Halcox Julian P  

Clinical Lipidology, Vol. 8, Iss. 3, 2013-06 ,pp. : 329-344

Future Medicine

Access to resources Recommend Favorite